COPPINI, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.661
EU - Europa 6.130
AS - Asia 1.850
SA - Sud America 229
OC - Oceania 44
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.951
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.626
PL - Polonia 2.140
RU - Federazione Russa 1.489
IT - Italia 958
SG - Singapore 572
HK - Hong Kong 513
IE - Irlanda 418
CN - Cina 361
SE - Svezia 300
BR - Brasile 206
DE - Germania 182
FI - Finlandia 117
GB - Regno Unito 102
JO - Giordania 102
IN - India 99
FR - Francia 97
CH - Svizzera 91
VN - Vietnam 74
ID - Indonesia 64
UA - Ucraina 61
AU - Australia 43
BE - Belgio 37
NL - Olanda 36
ES - Italia 33
CA - Canada 19
CI - Costa d'Avorio 19
GR - Grecia 16
RO - Romania 11
LT - Lituania 10
MX - Messico 10
BD - Bangladesh 8
KR - Corea 8
AR - Argentina 7
JP - Giappone 7
VE - Venezuela 7
PH - Filippine 6
AT - Austria 5
IQ - Iraq 5
MA - Marocco 5
PK - Pakistan 5
TR - Turchia 5
ZA - Sudafrica 5
EC - Ecuador 4
HU - Ungheria 4
PT - Portogallo 4
CZ - Repubblica Ceca 3
DK - Danimarca 3
GE - Georgia 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
IR - Iran 2
KZ - Kazakistan 2
NP - Nepal 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
TJ - Tagikistan 1
TZ - Tanzania 1
Totale 14.951
Salva come PNG Salva come JPEG
Città #
Warsaw 2.130
Santa Clara 1.698
Fairfield 745
Hong Kong 437
Dublin 406
Chandler 375
Ashburn 367
Singapore 359
Woodbridge 344
Seattle 321
Cambridge 297
Florence 292
Houston 258
Wilmington 242
Ann Arbor 217
Lawrence 128
Altamura 124
Beijing 121
Munich 111
Princeton 99
Bern 85
Mumbai 67
Jakarta 64
Buffalo 61
Boston 59
Dong Ket 57
Medford 56
San Diego 56
Shanghai 54
New York 49
Moscow 48
Rome 45
Boardman 42
Melbourne 42
Turku 39
Milan 37
Brussels 35
Falls Church 35
Helsinki 34
Hefei 30
Barcelona 27
Kent 25
London 25
Paris 25
Norwalk 23
São Paulo 20
Abidjan 19
Los Angeles 19
Andover 17
Dearborn 17
Frankfurt am Main 17
Phoenix 17
Redwood City 17
Scandicci 17
Bengaluru 13
Falkenstein 13
Guangzhou 13
Hillsboro 12
Bologna 11
Toronto 11
Yubileyny 11
Poggio A Caiano 10
Rio de Janeiro 10
Dallas 9
Redmond 9
Siena 9
Nanjing 8
The Dalles 8
Washington 8
Lappeenranta 7
Las Vegas 7
Perugia 7
Brasília 6
Chicago 6
Fontebuona 6
Mexico City 6
Naples 6
Pistoia 6
Prato 6
Santa Maria A Monte 6
Amsterdam 5
Athens 5
Brooklyn 5
Castelliri 5
Ho Chi Minh City 5
Livorno 5
Pavia 5
Portsmouth 5
Salerno 5
San Francisco 5
Saronno 5
Sesto Fiorentino 5
São Luís 5
Tianjin 5
Belo Horizonte 4
Bolzano 4
Cagliari 4
Chennai 4
Cleveland 4
Council Bluffs 4
Totale 10.669
Salva come PNG Salva come JPEG
Nome #
Ipertensione arteriosa LINEE GUIDA REGIONE TOSCANA 483
"Tuscany Registry for sAdden Cardiac DEath": metodo per la creazione di un registro multicentrico per la gestione di eventi di morte improvvisa in età giovanile 370
Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy. 353
Atrial Remodeling in Hypertrophic Cardiomyopathy 309
Optogenetics design of mechanistically-based stimulation patterns for cardiac defibrillation. 301
Pathogenesis of hypertrophic cardiomyopathy is mutation rather than disease specific: A comparison of the cardiac troponin T E163R and R92Q mouse models 276
Myocardial Dysfunction in Hypertrophic Cardiomyopathy: Primary Effects of Sarcomeric Mutations Versus Secondary EC-Coupling Remodelling 270
Regulation of intracellular Na+ in health and disease: pathophysiological mechanisms and implications for treatment 262
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 254
Oleuropein aglycone protects against MAO-A-induced autophagy impairment and cardiomyocyte death through activation of TFEB. 237
Late sodium current inhibitors to treat exercise induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium. 234
T-Tubular Electrical Defects Contribute to Blunted β-Adrenergic Response in Heart Failure. 229
Electrical defects of the transverse-axial tubular system in cardiac diseases 228
Quantitative assessment of passive electrical properties of the cardiac T-tubular system by FRAP microscopy 208
Optical investigation of action potential and calcium handling maturation of hiPSC-cardiomyocytes on biomimetic substrates 206
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center 204
A Novel Method of Isolating Myofibrils From Primary Cardiomyocyte Culture Suitable for Myofibril Mechanical Study 200
Modelling genetic diseases for drug development: Hypertrophic cardiomyopathy 193
Design of muscle contraction assist devices by liquid crystalline elastomers 191
Altered Ca2+ and Na+ homeostasis in human hypertrophic cardiomyopathy: Implications for arrhythmogenesis 189
Development of Light-Responsive Liquid Crystalline Elastomers to Assist Cardiac Contraction 185
Arrhythmia susceptibility in a rat model of acute atrial dilation 170
Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: a Translational Study 170
SODIUM-DEPENDENT GLUCOSE TRANSPORTERS (SGLT) IN HUMAN ISCHEMIC HEART: A NEW POTENTIAL PHARMACOLOGICAL TARGET 169
Selective Blockade of HCN1/HCN2 Channels as a Potential Pharmacological Strategy Against Pain 168
Liquid Crystalline Networks toward Regenerative Medicine and Tissue Repair 167
Impact of Mavacamten on Force Generation in Single Myofibrils from Rabbit Psoas and Human Cardiac Muscle 167
Real-time optical manipulation of cardiac conduction in intact hearts 165
Ranolazine prevents phenotype development in a mouse model of hypertrophic cardiomyopathy 160
Representativeness of the "Fiesole Misurata" study database for use in pharmaco-epidemiological investigations on adherence to antihypertensive medications 159
EFFECTS OF MAVACAMTEN, A FIRST-IN-CLASS INHIBITOR OF SARCOMERIC MYOSINS, ON THE MECHANICS OF ATRIAL AND VENTRICULAR MAMMALIAN MYOCARDIUM AND FAST SKELETAL MUSCLE 157
Advances in Stem Cell Modeling of Dystrophin-Associated Disease: Implications for the Wider World of Dilated Cardiomyopathy 154
UDP-glucose enhances outward K+currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors 152
The transverse-axial tubular system of cardiomyocytes. 152
Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives 150
Late Sodium Current Inhibition Reverses Electro-Mechanical Dysfunction in Human Hypertrophic Cardiomyopathy 147
Chronic Atrial Fibrillation Alters the Functional Properties of Ifin the Human Atrium 145
R4496C RyR2 mutation impairs atrial and ventricular contractility 141
Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. 140
Action potential propagation in transverse-axial tubular system is impaired in heart failure 140
Functional cardiac imaging by random access microscopy 135
Whole heart cytoarchitecture at micron-scale resolution 131
Cardiomyocyte-specific Gq signalling and arrhythmias: Novel insights from DREADD technology 130
Reply to entcheva: The impact of T-tubules on action potential propagation in cardiac tissue 130
Design of Biocompatible Liquid Cristal Elastomers Reproducing the Mechanical Properties of Human Cardiac Muscle 130
Defects in T-tubular electrical activity underlie local alterations of calcium release in heart failure 127
Time resolved depression of isometric force by Mavacamten in single myofibrils from rabbit psoas and human cardiac muscle 124
Response to Letter Regarding Article, "Late Sodium Current Inhibition Reverses Electromechanical Dysfunction in Human Hypertrophic Cardiomyopathy" 122
Impact of detubulation on force and kinetics of cardiac muscle contraction 121
Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy 120
Reversible dilated cardiomyopathy: into the thaumaturgy of the heart - Part 2 120
Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled Study 120
Impact of RyR2 mutation responsible for Cathecolaminergic Polymorphic Ventricular Tachycardia (CPTV) on the short term interval-force relationship of atrial and ventricular myocardium 119
Isolation and functional characterization of human ventricular cardiomyocytes from fresh surgical samples. 118
Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal 117
Pharmacological inhibition of serine proteases to reduce cardiac inflammation and fibrosis in atrial fibrillation 117
Novel Approach Targeting the Complex Pathophysiology of Hypertrophic Cardiomyopathy: The Impact of Late Sodium Current Inhibition on Exercise Capacity in Subjects with Symptomatic Hypertrophic Cardiomyopathy (LIBERTY-HCM) Trial 115
Clinical research in neonates and infants: Challenges and perspectives 114
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 113
Structural Mapping of Action Potential Propagation Pathways through Healthy and Diseased Heart 112
Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives 109
Clinical and Molecular Aspects of Cardiomyopathies: Emerging Therapies and Clinical Trials 108
Neural Effects on Cardiac Electrophysiology 108
[Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018] 108
Impact of R4496C RyR2 mutation on myocardial contractility 107
Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy 106
[Molecular targets and novel pharmacological options to prevent myocardial hypertrophic remodeling] 106
Optical clearing in cardiac imaging: A comparative study 106
Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models 105
Altered calcium regulation in isolated cardiomyocytes from Egr-1 knock-out mice 103
Cellular determinants of arrhythmic rysk in hypertrophic cardiomyopathy 103
Mavacamten has a differential impact on force generation in myofibrils from rabbit psoas and human cardiac muscle 102
Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM 101
Targets for therapy in sarcomeric cardiomyopathies. 101
Content of mitochondrial calcium uniporter (MCU) in cardiomyocytes is regulated by microRNA-1 in physiologic and pathologic hypertrophy 101
Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency 100
Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations 100
Transthyretin aggregates affect viability and functional properties of cardiomyocytes. 99
Electrophysiological and molecular remodeling in septal myocytes from fHCM patients 98
1473Microvascular coronary disease and myocardial fibrosis within the spectrum of hypertrophic cardiomyopathy: a histopathologic study 97
Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018 Abstracts 93
Letter to the Editor 93
Mavacamten depresses human atrial contractility in the same EC50% range as human ventricle 92
Myocardial dysfunction in hypertrophic cardiomyopathy (HCM): primary effects of sarcomeric protein mutations versus secondary E-C coupling remodeling 92
T-tubule remodeling in human hypertrophic cardiomyopathy 91
Optogenetic manipulation of cardiac electrical dynamics using sub-threshold illumination: dissecting the role of cardiac alternans in terminating rapid rhythms 90
Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy: cellular mechanisms and implications for diastolic function 85
Cardiac safety assessment of a novel recombinant bispecific antibody targeting the ether-à-go-go related gene 1 (hERG1)-β1 integrin macromolecular complex 81
Contraction and electrophysiological abnormalities in myofilament mutation-positive and mutation-negative human HCM myocardium 79
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy 79
Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy 79
Genetic characterization of juvenile sudden cardiac arrest and death in Tuscany: The ToRSADE registry 78
Transthyretin aggregates affect viability and electrical properties of cardiomyocytes 76
Optogenetic confirmation of transverse‐tubular membrane excitability in intact cardiac myocytes 75
Novel pharmacological approaches for paediatric hypertrophic cardiomyopathy 75
Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside 73
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center 71
Ion Channel Impairment and Myofilament Ca2+ Sensitization: Two Parallel Mechanisms Underlying Arrhythmogenesis in Hypertrophic Cardiomyopathy 70
Novel method of obtaining myofibrils from cardiomyocyte cultures 70
Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium 67
Totale 14.467
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.888
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.888
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.833 127 167 76 198 140 140 113 135 151 403 90 93
2021/2022902 41 49 78 41 50 51 51 46 49 65 149 232
2022/20232.020 178 365 105 126 122 310 236 104 273 30 65 106
2023/2024911 37 92 112 38 55 129 53 186 18 59 51 81
2024/20255.802 241 668 378 817 1.480 703 136 389 298 139 246 307
2025/2026123 123 0 0 0 0 0 0 0 0 0 0 0
Totale 15.159